Última Hora: "Governo quer criar condições ?para que os jovens tenham capacidade de ter filhos mais cedo? - PÚBLICO" Tue, 21 Jan 2020 06:30:00 GMT    "Vento mantém quatro distritos sob aviso amarelo - TVI24" Tue, 21 Jan 2020 06:19:00 GMT    "Seis vítimas mortais e transmissão entre humanos fazem disparar receios do coronavírus - RTP" Tue, 21 Jan 2020 10:10:00 GMT    "Já foram publicadas as tabelas de retenção na fonte. Saiba quanto vai descontar de IRS todos os meses - ECO Economia Online" Tue, 21 Jan 2020 09:06:11 GMT    "Condutor que matou irmã de Djaló condenado a 16 anos de prisão - A Bola" Tue, 21 Jan 2020 11:37:25 GMT    "Os cinco desafios de Rui Rio para devolver o PSD ao poder - Diário de Notícias - Lisboa" Mon, 20 Jan 2020 00:17:50 GMT   "Mais de 400. Todas as empresas em que Isabel dos Santos teve participações - Diário de Notícias - Lisboa" Tue, 21 Jan 2020 11:36:00 GMT    "Jovem que esfaqueou colega em Gondomar acusado de tentativa de homicídio - Jornal de Notícias" Tue, 21 Jan 2020 11:04:00 GMT    "PSP condiciona entradas no aeroporto de Lisboa. Manifestação tornou-se mais ruidosa - PÚBLICO" Tue, 21 Jan 2020 10:18:00 GMT    "Rui Tavares sentiu "vergonha alheia" com discurso de Joacine - Jornal de Notícias" Tue, 21 Jan 2020 09:54:00 GMT      Para más noticias, haga clic aquí.

Zona de Acceso
       
       
¿Recordarme? 

Bajada de
--0.85 (+0.98%) Pfizer - [Ticker: PFE]Gráfico Pfizer  Noticias Pfizer  Descargar Históricos de Metastock Pfizer y Otros  Análisis Técnico Pfizer  
Última Transacción45,140Hora de Cotización2018-12-04 - 00:00:00
Variación--0.85 (+0.98%)Rango 52 Semanas[0,000 - 0,000]
Máximo46,470Mínimo45,110
Volumen26.062.310Volumen Medio (3m)0
Demanda / Oferta35,330 x 5.700 - 35,340 x 8.100Yield
Cierre Anterior45,990PER0,00%
Apertura46,230EPS0,00
Fecha Ex-DividendoFecha Dividendo
Capitalización Bursátil0 Objetivo Estimado 1 Año0,000
Nota: Los datos pueden tener un retraso de algunos minutos.
Ver cotizaciones de otros activos

Intradía   5 días   1 mes   3 meses   6 meses   1 año   2 años   5 años   10 años            Utilice este gráfico en su sitio web!
Gráfico de Pfizer -  [Ticker: PFE]
Cambiar para Gráfico Interactivo de Análisis Técnico de Pfizer

Últimos 10 Tópicos en el Foro relacionados con Pfizer:
Tópico/MensajeAutorFecha Hora
 Niveles técnicos semanales del EURUSD del 23-27 junio d...Aaronhon
2019-04-06 - 13:08
 Niveles técnicos semanales del EURUSD del 23-27 junio d...Douglasguile
2019-04-06 - 05:00
 Niveles técnicos semanales del EURUSD del 23-27 junio d...Charlesdak
2019-04-06 - 04:18
 Niveles técnicos semanales del EURUSD del 23-27 junio d...Aaronhon
2019-04-05 - 23:52
 Analítica de mercados financieros de Libertex -> dwnpzr...Gordonskelt
2019-04-05 - 22:59
 Niveles técnicos semanales del EURUSD del 23-27 junio d...Charlesdak
2019-04-05 - 07:44
 Analítica de mercados financieros de Libertex -> 255w8y...Charlesdak
2019-04-05 - 01:52
 Niveles técnicos semanales del EURUSD del 23-27 junio d...Aaronhon
2019-04-04 - 20:37
 GESTION DE LOS ÚLTIMOS SWINGS CON ABE, BME, POP, SAN, J...Kennethbuh
2019-04-04 - 09:56
 Niveles técnicos semanales del EURUSD del 23-27 junio d...Aaronhon
2019-04-04 - 09:40

 Noticias de Pfizer [PFE]:   (ordenadas por relevancia)

Bae Negocios

Pfizer desinvierte en Argentina
Bae Negocios
La norteamericana Pfizer le está bajando la persiana a su negocio de OTC en Argentina y Chile desde el 1° de diciembre. Afectará a sus marcas Centrum y Dristan, no a Ibupirac. A la vez se formalizará la desvinculación de un equipo de cerca de 20 ...

y más »

Zacks.com

Pfizer (PFE) Stock Moves -1.78%: What You Should Know
Zacks.com
Wall Street will be looking for positivity from PFE as it approaches its next earnings report date. This is expected to be January 29, 2019. The company is expected to report EPS of $0.64, up 3.23% from the prior-year quarter. Meanwhile, the Zacks ...


Pfizer initiates phase 3 trial of tofacitinib for ankylosing spondylitis
Healio
Pfizer has initiated a global phase 3 study intended to evaluate the safety and therapeutic activity of tofacitinib among adult patients with active ankylosing spondylitis who have had an inadequate response or intolerance to standard treatment with ...


Arizona Daily Star

Erika Bean, Pfizer, Inc.
Arizona Daily Star
Since 2008, Erika has worked for Pfizer, Inc and is a hospital account manager and a member of Leadership Lab, a professional development track for emerging leaders within the Pfizer organization. Erika has served on the Junior League of Tucson Board ...


The Australian Financial Review

How CEOs respond when attacked by Trump, from Pfizer and BMW to Nike and Apple
The Australian Financial Review
Bosses of the world's largest corporations are still learning to deal with one modern peril: when President Donald Trump shows he's not afraid to call them out on Twitter. General Motors is the latest example. Even though chief executive officer Mary ...


Zacks.com

AbbVie Settles With Pfizer for Humira Biosimilar in US
Zacks.com
In the EU, Pfizer can launch Humira biosimilar when it gets approval from the European Medicines Agency. Per the terms of the settlement, Pfizer will pay royalties to AbbVie once its cheaper version is launched. AbbVie will make no payments to Pfizer.
AbbVie, Pfizer reach licencing agreement for biosimilar Humira ...pharmaphorum

los 8 artículos informativos »

Pfizer's Rituxan biosimilar successful in late-stage study; shares up ...
Seeking Alpha
Pfizer (PFE) is up 1% premarket on light volume following its announcement of positive results from a Phase 3 clinical trial, REFLECTIONS B328-06, evaluati.

y más »

TheStreet.com

Pfizer Is in Breakout-Mode This Fall: Chart
TheStreet.com
At a glance, it's hard to miss the overall trend in shares of Pfizer. This stock has spent much of the last six months moving up and to the right in a well-defined uptrend. In October, when the rest of the broad market corrected sharply, Pfizer's dip ...


Investorplace.com

Monday's Vital Data: Pfizer, Goldman Sachs and Caterpillar
Investorplace.com
Pfizer (NYSE:PFE) saw renewed options interest after breaking out to fresh seventeen-year highs. Goldman Sachs (NYSE:GS) put volume ramped as the stock fell to a new 52-week low. Finally, Caterpillar (NYSE:CAT) was flooded with activity as its ongoing ...


Crain's Chicago Business

AbbVie, Pfizer settle Humira copycat dispute
Crain's Chicago Business
Pfizer has settled with AbbVie for a nonexclusive intellectual property license to market its proposed Humira biosimilar in the United States on Nov. 20, 2023, and in Europe upon approval from the European Medicines Agency, AbbVie said in a statement ...
Pfizer Joins Pharmaceutical Stocks With Humira Biosimilar Deal ...Investor's Business Daily
AbbVie inks Humira patent deal No. 7, delaying Pfizer's US biosim launch until late 2023FiercePharma
Pfizer secures Humira license from AbbVieSeeking Alpha

los 13 artículos informativos »

pharmaphorum

Pfizer strikes deal with Chinese online pharmacy Jianke
pharmaphorum
Pfizer is set to implement a new retail, hospital services and internet healthcare strategy in China as part of a deal with local online pharmacy and health services platform Jianke. The strategic cooperation agreement will also see the pharmaceutical ...


The RNS Daily

Pfizer Inc. (PFE) Could Be Remarkably Fruitful
The RNS Daily
Some analysts have a lowest price target on Pfizer Inc. (NYSE:PFE) of $37, which would mean a -19.55% gain in value. The closing share price quoted for December 03, 2018 was $45.99. The -0.52% drop might have been tempting for an investor to sell at ...
Market Value should Soar in coming Months: Pfizer Inc. (PFE)NMSU N?ws
Pfizer Inc. (PFE) Position Cut by Pin Oak Investment Advisors Inc.Fairfield Current
Considering an investment in shares of Pfizer Inc. (PFE)?MONReport
StocksNewsPro (press release) -News Room Alert (press release)
los 135 artículos informativos »

Wallstreet Investorplace

Pfizer Inc. (PFE) look forward to 2.06% EPS growth for next year
Wallstreet Investorplace
Pfizer Inc. (PFE) predicted to achieve earnings per share (EPS) growth of 68.20% for this year while EPS growth expected to touch 2.06% for next year. The company reported EPS (ttm) of 2.4. Take a view on its long-term annual earnings per share (EPS) ...


The Pharma Letter

AstraZeneca and Pfizer drugs reimbursed in Australia
The Pharma Letter
Meanwhile, the current PBS listing of Genotropin and Genotropin GoQuick (somatropin) from US pharma giant Pfizer (NYSE: PFE) will be extended to include eligible adults. It is currently only available for children through the PBS. This medicine will ...


Motley Fool

3 Big Pharma Stocks Hitting 52-Week Highs -- Are They Buys?
Motley Fool
And three big pharma stocks are enjoying such a great year that they're up by more than 28% and recently hit 52-week highs: Merck (NYSE:MRK), Eli Lilly (NYSE:LLY), and Pfizer (NYSE:PFE). Here's why these three stocks have performed so well and ...

y más »
Para más noticias de Pfizer hacer clic aquí:
Noticias de Pfizer

Anchura de la Página:

 Imagen de Fondo:

Copyright@2009-2020 - BolsaES.com, todos los derechos reservados.
Foro de Bolsa Cotizaciones Noticias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters